Guardian Capital LP Amgen Inc Transaction History

Guardian Capital LP

$2.47 Billion
Q3 2024

A detailed history of Guardian Capital LP transactions in Amgen Inc stock. As of the latest transaction made, Guardian Capital LP holds 22,987 shares of AMGN stock, worth $6.08 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

22,987

Previous 23,119 0.57%

Holding current value

$6.08 Million

Previous $7.22 Million 2.53%

% of portfolio

0.3%

Previous 0.3%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $40,838 - $44,534	-132 Reduced 0.57%	22,987 $7.41 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $7,882 - $9,579	30 Added 0.13%	23,119 $7.22 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $37,104 - $44,789	-138 Reduced 0.59%	23,089 $6.56 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $60,089 - $67,788	-235 Reduced 1.0%	23,227 $6.69 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $801,352 - $994,900	-3,665 Reduced 13.51%	23,462 $6.31 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $4,071 - $4,814	19 Added 0.07%	27,127 $6.02 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $26,191 - $31,923	-116 Reduced 0.43%	27,108 $6.55 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $38,706 - $49,180	-169 Reduced 0.62%	27,224 $7.15 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $6.15 Million - $6.93 Million	27,393 New	27,393 $6.17 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $226,437 - $251,816	-965 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $190,886 - $234,244	965 New	965 $228,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $200,281 - $265,628	-1,099 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1,513 - $1,945	-8 Reduced 0.72%	1,099 $265,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $15.6 Million - $18.7 Million	-89,430 Reduced 98.78%	1,107 $214,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $3.97 Million - $4.66 Million	23,830 Added 35.72%	90,537 $16.7 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $884,635 - $997,177	-4,891 Reduced 6.83%	66,707 $12.7 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $2.32 Million - $2.71 Million	12,994 Added 22.17%	71,598 $13.9 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $214,380 - $241,685	-1,157 Reduced 1.94%	58,604 $12.1 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $339,572 - $381,412	-2,045 Reduced 3.31%	59,761 $11 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $1.81 Million - $2.12 Million	10,690 Added 20.91%	61,806 $10.5 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $94,016 - $105,044	-557 Reduced 1.08%	51,116 $8.89 Million
Q3 2017 Nov 15, 2017	SELL	$167.29 - $191.0 $89,332 - $101,994	-534 Reduced 1.02%	51,673 $9.63 Million
Q2 2017 Aug 14, 2017	BUY	N/A	52,207	52,207 $8.99 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital LP with notifications on news.

Account

Guardian Capital LP Amgen Inc Transaction History